Biochemists open path to molecular 'chaperone' therapy for metabolic disease
Tuesday, October 9, 2012 - 11:02
in Biology & Nature
Experts in revealing molecular structure by X-ray crystallography have identified two new small "chaperone" molecules that may be useful in treating the inherited metabolic disorder known as Schindler/Kanzaki disease. This offers hope for developing the first ever drug treatment for this very rare disease.